<DOC>
	<DOCNO>NCT02153567</DOCNO>
	<brief_summary>Background : Functional dyspepsia one commonest digestive disorder . The pathophysiology functional dyspepsia ( FD ) uncertain . Clinical experience community study show FD strongly associate common mood disorder especially depression anxiety disorder , treat serotonin selective uptake receptor ( SSRI ) . Our previous study show relief FD symptom association change plasma serotonin ghrelin profile . However , correlation plasma serotonin level FD patient treat SSRI lack study . Indication : Functional dyspepsia patient Study center ( ) : Prince Wales Hospital , Hong Kong Aims : - To evaluate effect SSRI treatment change plasma serotonin level - To evaluate relationship dyspeptic symptom change plasma serotonin level Study medication : Escitalopram ( Lexapro ) 5mg daily first 2 week , 10 mg daily 8 week versus Placebo 10 week Study design : Double-blind randomized placebo-controlled trial Number subjects:72 - 36 patient ( 18 male 18 female ) 36 age-and-sex-matched healthy control Patient population : Functional dyspepsia patient age 18-60 , element anxiety depression Duration study : 1 June 2013 - 30 November 2015 Primary variable ( ) : Change serotonin ghrelin level blood plasma medication treatment Secondary variable ( ) : Rate adequate relief use global symptom assessment symptom score Number visit : 2</brief_summary>
	<brief_title>SSRI Study Functional Dyspepsia ( SS )</brief_title>
	<detailed_description>Baseline assessment : - Demographic : age , gender - Anthropometric measurement : body mass index , height , weight waist circumference - FGI Screening Questionnaire ( v.3 , 20101011 ) screen functional gastrointestinal disorder accord Rome III criterion . - Duration dyspeptic symptom record - A combined Functional GI symptom Questionnaire ( FGISQ ) ( version : FGISQ 20110504 ) base recall past 7 day use assessment al GI symptom include regurgitation , heartburn , epigastric pain , postprandial fullness , abdominal pain , diarrhea , constipation etc . All question use 4-point ( 0-3 ) Likert scale . - Patient Health Questionnaire ( PHQ ) Hospital Anxiety Depression Scale ( HADS ) use screen concomitant psychological disorder depression generalize anxiety disorder . - BECK Anxiety Inventory ( BAI ) , BECK Depression Inventory ( BDI ) Anxiety Sensitivity Index-Revised ( ASI-R ) use monitor change mood status . - Trained interviewer perform semi- structured clinical interview use Chinese-Bilingual version Structured Clinical Interview DSM Mental Disorders-IV ass lifetime current diagnosis depressive anxiety disorder ( female patient ) Satiety test ghrelin profile : After overnight fast , patient instruct ingest Ensure® ( 1.06 kcal/ml ; 22 % fat , 64 % carbohydrate , 14 % protein ) constant rate 30ml/min fix calorie test 28 minute ( Total calorie : 890.4 kcal ) . They require complete Fullness Rating Scale ( FRS ) 3-min interval ( ie . 0min , 3min , 6min… ) . Initial Blood sample 16 ml take ( 10ml take preprandially storage future identification biomarkers functional GI disorder 6 ml assay ghrelin serotonin profile ) . Another blood sample ( 6 ml ) take 120min assay ghrelin serotonin profile . The test perform baseline ( V1 ) medication treatment ( V2 ) . Baseline neuroimaging study ( female subject ) : 1 . Structural MRI MRI perform use 3 Tesla MRI scanner ( Achieva TX series , Philips Healthcare , Best , Netherlands ) . Patients lie supine MRI scan table . In study , high resolution structural image acquire use 8-channel receive-only head coil transverse orientation section brain use sagittal 3D T1-weighted sequence ( TR/TE : 7.4/3.4 m , field view : 250x250 mm , 285 contiguous slice , 0.6 mm ( RL ) thickness , reconstruction matrix : 240x240 , flip angle 8o ) . Analysis- Voxel-based morphometry ROI approach - We adopt voxel-based morphometry locate difference white matter grey matter globally . The volume structure interest quantify segment automatically register brain template ( atlas label ) construct base Chinese structural brain MRI . The volume region interest compare FD normal control group , include left ventrolateral prefrontal cortex , dorsolateral prefrontal cortex , bilateral insular cortex , bilateral anterior midcingulate cortex , well corona radiata . 2 . Diffusion Tensor Imaging DTI obtain use single-shot echo planar image sequence . Diffusion sensitize gradient apply along 32 non-linear direction ( b = 1000 s/mm2 ) , together acquisition without diffusion weighting ( b = 0 s/mm2 ) . The image parameter 70 continuous axial slice slice thickness 2 mm gap , field view = 224x224 mm2 , repetition time/echo time = 8924/60 m , acquisition matrix = 112x109 . A parallel imaging acceleration factor 2.5 use reduce scan time . Analysis- We compare whole brain FA/ADC map fiber tract different ROIs state . The statistical group comparison whole brain FA/ADC value perform follow voxel-based tract base spatial-statistics ( TBSS ) , automate method compare FA value align image multiple subject . The advantage apply TBSS lie robust `` voxel-wise '' cross-subject statistic , good image alignment , project data onto group-mean tract skeleton . Aside whole brain FA/ADC analysis , also intend compare fiber density FA/ADC value specific ROIs . The ROI DTI data identify register structural data map ROI segmentation result structural data . The whole brain tractography perform density fiber ROI calculate compare two group . The mean FA/ADC value ROI also compare two group . The test perform baseline ( V1 ) female patient control only.Functional neuroimaging assessment ( female patient ) Functional MRI -resting state functional connectivity For resting-state fMRI scanning , subject instruct eye close 6 minute hold still without fall asleep . Subjects consider compliant instruction exclude study . Resting fMRI data collect use single-shot echo-planar sequence sensitive BOLD contrast ( TR : 2050ms , TE : 25ms , flip angle 90o , slab thickness : 150 mm , field view : 205x205 mm , image matrix : 64x64 , parallel image acceleration factor 2 ) acquire 150 dynamic scan condition . BOLD image acquire nominal in-plane resolution 3.2x3.2 mm temporal resolution 2 per dynamic scan . Analysis- The functional brain connectivity derive rest state functional MRI ( rs-fMRI ) data compare two group . In particular , rs-fMRI data co-registered structural MRI data . Ninety-nine brain region automatically partition map Chinese brain atlas 90 labeled region . The correlation low frequency time series data calculate every two region among 90 region , base connectivity matrix generate thresholded construct functional brain connectivity network . The global , regional , local network characteristic derive compare two group . Magnetic Resonance Spectroscopy : Localized proton MRS perform structural image obtain guide position volume interest leave insula bilateral pregenual anterior cingulate cortex leave primary somatosensory cortex . Signal reception 1H-MRS achieve use 8-channel received-only head coil . Water-suppressed spectrum acquire region measure 2 x 2 x 2 cm3 use point-resolved spectroscopic ( PRESS ) sequence ( TR/TE 2000/23 m ) . A short TE PRESS sequence employ enable optimal detection metabolites interest glutamate-glutamine ( Glx ) peak . Optimization procedure spectroscopy comprise automate receiver gain frequency adjustment , second-order shimming gradient tuning . Water suppression achieve use automate selective inversion recovery technique . From region , 128 water-suppressed signal acquire spectral bandwidth 1,000Hz . The averaged signal export processed off-line computer . MRS Data Analysis Short TE spectrum acquire analyzed use fully automate user-independent spectral software package LCModel , frequency-domain postprocessing tool well suited quantify complex signal Glx ( ref ) . The advantage LCModel employ information whole chemical shift range spectrum fit amplitude model spectra . The metabolite interest study NAA , Cho , mI , Glx , glutamine , glutamate , GABA creatinine . Metabolite ratio mI/Cr , Glx/Cr , NAA/Cho , NAA/Cr Cho/Cr calculate base peak concentration value obtain LCModel analysis . The test perform baseline ( V1 ) medication treatment ( V2 ) female patient . Randomization unblinding treatment arm Randomization perform gender independently , gender group ( male female ) consist 9 patient treatment arm 9 patient control arm . The random allocation sequence obtain computer-generated list random number block 18 . Concealed allocation achieve independent staff label Escitalopram 5mg/10mg placebo accord computer-generated list . The study arm allocate study number print seal individual envelope consecutive study number . After satiety test baseline ( V1 ) , research staff dispense seal package study medication accord patient 's study number give consecutive order accord patient 's gender . Both investigator , research staff patient aware treatment assignment throughout study . At final visit ( V2 ) , study arm patient assign unblinded opening prepare seal envelope patient 's study number . Physician consultation give decide management disease base patient 's symptom response current medication treatment . Further titration ( either dose escalation taper ) determine discretion physician base individual response patient allocate Escitalopram group . The patient would continue disease management hospital 's specialty clinic final visit ( V2 ) . Medication adherence measure pill count final visit ( V2 ) . Follow-up questionnaire assessment : The patient report individual dyspeptic mood symptom weekly basis week 8 complete follow self-administered questionnaire : FGISQ , BAI BDI . ASI-R repeat week 8 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>• Patients functional dyspepsia fulfill Rome III criterion Has element anxiety depression report baseline screen HADS ( either subscale HADS HAS HDS score 8 high ) Age 1860 Provision write consent No evidence structural disease ( include upper endoscopy ) likely explain dyspeptic symptom • Diabetes mellitus Organic brain syndrome Moderate severe Depression diagnose Structured Clinical Interview DSMIV conduct psychiatrist train research staff History psychosis , bipolar disorder substance abuse/dependence On psychiatric medication ( SSRI , SNRI , tricyclic antidepressant , anxiolytic ) Has suicidal ideation past two week screen PHQ baseline assessment Diagnosis GERD GERDQ questionnaire ( GERDQ score ≥8 ) include FGI Screening Questionnaire ( v.3 ) complete baseline visit Concurrent medication affect GI motility History gastric surgery Organic disease cause dyspepsia H. pylorus infection Use PPI NSAID past 4 week Pregnancy Known hypersensitivity SSRI Unable read Chinese illiterate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Functional dyspepsia</keyword>
	<keyword>symptom response</keyword>
	<keyword>postprandial fullness</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Depression</keyword>
</DOC>